ViewRay (ViewRay) EPS (Basic) : $-0.60 (TTM As of Mar. 2023)

View and export this data going back to 2014. Start your Free Trial

What is ViewRay EPS (Basic)?

ViewRay's basic earnings per share (Basic EPS) for the three months ended in Mar. 2023 was $-0.16. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.60.

ViewRay's EPS (Diluted) for the three months ended in Mar. 2023 was $-0.16. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.60.

ViewRay's EPS without NRI for the three months ended in Mar. 2023 was $-0.16. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2023 was -0.59.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

ViewRay EPS (Basic) Historical Data

The historical data trend for ViewRay's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViewRay EPS (Basic) Chart

ViewRay Annual Data

Trend

Nov13

Nov14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Basic)

Get a 7-Day Free Trial

-0.98

-1.18

-0.73

-0.67

-0.59

ViewRay Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EPS (Basic)	Get a 7-Day Free Trial															-0.14	-0.15	-0.14	-0.15	-0.16

ViewRay EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

ViewRay's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as

Basic EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-107.33	-	0)	/	180.697
	=	-0.59

ViewRay's Basic EPS for the quarter that ended in Mar. 2023 is calculated as

Basic EPS (Q: Mar. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-28.859	-	0)	/	182.311
	=	-0.16

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.60

ViewRay (OTCPK:VRAYQ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ViewRay EPS (Basic) Related Terms

Thank you for viewing the detailed overview of ViewRay's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

ViewRay (ViewRay) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViewRay Inc (OTCPK:VRAYQ) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1099 18th Street, Suite 3000, Denver, CO, USA, 80202

Website

https://www.viewray.com

ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures, and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, the Monte Carlo treatment planning system, etc. The company holds the license for its combination of MRI and radiation therapy technologies. Geographically, it derives a majority of its revenue from the United States.

Executives

Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
B Kristine Johnson	director	366 FERNDALE RD S, WAYZATA MN 55391
Sanket Shah	officer: SVP, General Counsel	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Farhad Fred Ebrahimi	10 percent owner	191 UNIVERSITY BLVD., #246, DENVER CO 80206
Caley Castelein	director	THOM. WEISEL HEALTHCARE VENTURES, ONE MONTGOMERY STREET, SAN FRANCISCO CA 94104
Paul Jr Ziegler	officer: Chief Commercial Officer	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Scott William Drake	director, officer: President and CEO	9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Adam Andrew Podbelski	officer: SVP, Customer Services	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Jacob Edward Signoriello	officer: Chief Financial Officer	C/O VIEWRAY, INC., 1099 18TH STREET, SUITE 3000, DENVER CO 80202
James F. Dempsey	director, officer: Chief Scientific Officer	C/O VIEWRAY INCORPORATED, 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Burke William P. Mr.	officer: Chief Financial Officer	HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Susan C Schnabel	director	C/O CREDIT SUISSE FIRST BOSTON, 11 MADISON AVE, NEW YORK NY 10010
Brian K Roberts	director	DIGITAS INC.,, 800 BOYLSTON STREET, BOSTON MA 02199
Zachary William Stassen	officer: Chief Financial Officer	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Daniel Jeffrey Moore	director	100 CYBERONICS BVLD, HOUSTON TX 77058